Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cynthia Behling

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
JHEP Reports : Innovation in Hepatology|January 16, 2023
A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosisStephen A Harrison, Peter J Ruane, Bradley Freilich, et al.
Gut|November 20, 2020
MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosisJinho Jung, Rohan R Loomba, Kento Imajo, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|October 17, 2024
MASLD: What We Have Learned and Where We Need to Go-A Call to ActionSedighe Hosseini Shabanan, Vitor F Martins, Tanya Wolfson, et al.
The Journal of Pediatrics|April 4, 2017
Low and High Birth Weights Are Risk Factors for Nonalcoholic Fatty Liver Disease in ChildrenKimberly P Newton, Haruna S Feldman, Christina D Chambers, et al.
Hepatology (Baltimore, Md.)|September 27, 2019
Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver DiseaseVeeral H Ajmera, Amy Liu, Seema Singh, et al.
Journal of Hepatology|September 25, 2025
Genetic and non-genetic drivers of histological progression and regression in MASLDEduardo Vilar-Gomez, Katherine P Yates, David E Kleiner, et al.
Hepatology (Baltimore, Md.)|January 23, 2020
Multicenter Validation of Association Between Decline in MRI-PDFF and Histologic Response in NASHRohit Loomba, Brent A Neuschwander-Tetri, Arun Sanyal, et al.
Inflammatory Bowel Diseases|January 14, 2014
Histologic evaluation of ulcerative colitis: a systematic review of disease activity indicesMahmoud H Mosli, Brian G Feagan, William J Sandborn, et al.
Gastroenterology|May 1, 2023
Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter StudyDaniel Q Huang, Laura A Wilson, Cynthia Behling, et al.
Hepatology (Baltimore, Md.)|May 26, 2005
Design and validation of a histological scoring system for nonalcoholic fatty liver diseaseDavid E Kleiner, Elizabeth M Brunt, Mark Van Natta, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
JHEP Reports : Innovation in Hepatology|January 16, 2023
A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosisStephen A Harrison, Peter J Ruane, Bradley Freilich, et al.
Gut|November 20, 2020
MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosisJinho Jung, Rohan R Loomba, Kento Imajo, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|October 17, 2024
MASLD: What We Have Learned and Where We Need to Go-A Call to ActionSedighe Hosseini Shabanan, Vitor F Martins, Tanya Wolfson, et al.
The Journal of Pediatrics|April 4, 2017
Low and High Birth Weights Are Risk Factors for Nonalcoholic Fatty Liver Disease in ChildrenKimberly P Newton, Haruna S Feldman, Christina D Chambers, et al.
Hepatology (Baltimore, Md.)|September 27, 2019
Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver DiseaseVeeral H Ajmera, Amy Liu, Seema Singh, et al.
Journal of Hepatology|September 25, 2025
Genetic and non-genetic drivers of histological progression and regression in MASLDEduardo Vilar-Gomez, Katherine P Yates, David E Kleiner, et al.
Hepatology (Baltimore, Md.)|January 23, 2020
Multicenter Validation of Association Between Decline in MRI-PDFF and Histologic Response in NASHRohit Loomba, Brent A Neuschwander-Tetri, Arun Sanyal, et al.
Inflammatory Bowel Diseases|January 14, 2014
Histologic evaluation of ulcerative colitis: a systematic review of disease activity indicesMahmoud H Mosli, Brian G Feagan, William J Sandborn, et al.
Gastroenterology|May 1, 2023
Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter StudyDaniel Q Huang, Laura A Wilson, Cynthia Behling, et al.
Hepatology (Baltimore, Md.)|May 26, 2005
Design and validation of a histological scoring system for nonalcoholic fatty liver diseaseDavid E Kleiner, Elizabeth M Brunt, Mark Van Natta, et al.
Pageof 9